Unbiased Analysis of Today's Healthcare Issues
I have written about the 340b program a number of times on this blog in the past (e.g., “The 340B Program: An Overview“, “340B Facts and Figures“). A new commentary by Thomas and Schulman (2020) in Health Services Research provides some additional information. For instance, why was 340B originally enacted? Blame the Medicaid Drug Rebate…
Janet Currie has a nice review article (Currie 2020) in Health Economics covering this topic. She summarizes the literature as follows: In the past 20 years, there has been an explosion of research demonstrating that child health is an important form of human capital. Healthier children live longer and healthier lives, get more education, and…
Kaiser Family Foundation has a nice overview of how Medicaid pays for prescription drugs. Below, I except from this helpful piece, but do check out the full article here. One point that many may not realize is that State Medicaid Agencies do not actually buy pharmaceuticals directly from manufacturers. Rather, they reimburse retail pharmacies that…
Every year, the Congressional Budget Office projects how the federal budget will look over the coming decade. For the coming decade, the numbers look grim. Federal deficits in CBO’s baseline average $1.2 trillion per year and total $11.6 trillion over the 2020– 2029 period…Those deficits would average 4.4 percent of gross domestic product (GDP). Other…
Last week, a federal judge blocked Arkansas and Kentucky from requiring individuals to work in order to receive Medicaid benefits. Prior to that decision, 9 states had been approved to implement Medicaid work requirements. At first glance, a work requirement does not make a lot of sense. If you are very sick and on Medicaid,…
How did Medicaid expansion affect prescription drug use? At first glance, one would think that prescriptions increased; more insurance lowers patient out-of-pocket cost so we would expect more prescriptions. Medicaid insurance may crowd out other forms of insurance; if those other forms of insurance covered more drugs, then perhaps utilization would go down. A study…
From Sen and DeLeire (2018): …premiums of Marketplace plans are 11% lower in Medicaid expansion states, controlling for demographic and health characteristics as well as measures of health care access. These results are consistent with evidence on the composition of the private insurance risk pool in expansion versus nonexpansion states and associated differences in expected…
A number of people talk about Medicaid “best price”…but what is it really? StatNews provides a concise overview: The Medicaid best price law, enacted in 1990, requires drug manufacturers to charge the Medicaid program the lowest or “best” price they negotiate with any other buyer and send a rebate check to every state Medicaid department so…
That is what is proposed by Dana Goldman in his article in The Hill. He uses the case of Louisiana’s approach to pay for treatments for the hepatitis C virus (HCV) to make the point. The [Louisiana] Department of Health is working on a new strategy to expand access—one that involves a licensing deal. The state…
Federal funding for the Children’s Health Insurance Program (CHIP) ended in September 2017. This caused a stir as many parent’s relied on CHIP for their children’s health insurance. In January 2018, however, the federal government’s passed a six-year CHIP funding extension and resolved to continue to fund this program. The headlines at the time showed pictures of…